Zobrazeno 1 - 10
of 21
pro vyhledávání: '"John J. Panos"'
Publikováno v:
Metabolic Brain Disease. 36:1803-1816
Alzheimer's disease (AD) is the fourth leading cause of death in the United States and the most common cause of adult-onset dementia. Recent results suggest an increased prevalence and severity in African Americans compared to Caucasians. Our underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cbb035a63e9cdd08d172649c160861e
https://doi.org/10.1007/s11011-021-00754-z
https://doi.org/10.1007/s11011-021-00754-z
Publikováno v:
Metabolic Brain Disease. 35:121-133
Chronic neuroinflammation is strongly associated with AD and altered peripheral and central levels of chemokines and cytokines have been frequently described in those with AD. Given the increasing evidence of ethnicity-related differences in AD, it w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6eb61a17530d9c5b5a4e8e9a1ea69b3
https://doi.org/10.1007/s11011-019-00512-2
https://doi.org/10.1007/s11011-019-00512-2
Publikováno v:
Metabolic brain disease. 36(7)
Alzheimer's disease (AD) is the fourth leading cause of death in the United States and the most common cause of adult-onset dementia. Recent results suggest an increased prevalence and severity in African Americans compared to Caucasians. Our underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ddbd39e83389ef6029abaefafa8e01d1
https://pubmed.ncbi.nlm.nih.gov/34021875
https://pubmed.ncbi.nlm.nih.gov/34021875
Publikováno v:
Journal of Alzheimer's Disease. 59:57-66
BACKGROUND Alzheimer's disease (AD) presents with an earlier onset age and increased symptom severity in African Americans and Hispanics. OBJECTIVE Although the prevalence of plaques and tangles may not exhibit ethnicity-related differences, levels o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::654d81e7bf74f9984e85f59f19adaa4f
https://doi.org/10.3233/jad-170204
https://doi.org/10.3233/jad-170204
Autor:
John J. Panos, Zhen He, Tetyana Konak, Diane B. Miller, James P. O'Callaghan, Syed Z. Imam, Merle G. Paule, Serguei Liachenko, James Raymick, Li Cui
Publikováno v:
Neuromethods ISBN: 9781493992270
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52fde516c62501f29d8c1d7b0328d6d7
https://doi.org/10.1007/978-1-4939-9228-7_12
https://doi.org/10.1007/978-1-4939-9228-7_12
Publikováno v:
Neurotoxicology and Teratology. 45:70-74
Attention Deficit Hyperactivity Disorder (ADHD) is estimated to affect 4-5% of the adult human population (Kessler et al., 2006; Willcutt, 2012). Often prescribed to attenuate ADHD symptoms (Nair and Moss, 2009), methylphenidate hydrochloride (MPH) c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f52f30bf4b7df27b97abc17d4b1c2a4
https://doi.org/10.1016/j.ntt.2014.08.001
https://doi.org/10.1016/j.ntt.2014.08.001
Publikováno v:
Alzheimer's & Dementia. 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd1b07940a1502d5fbbbc1178bc2fc57
https://doi.org/10.1016/j.jalz.2016.06.1081
https://doi.org/10.1016/j.jalz.2016.06.1081
Autor:
John J. Panos, Lisa E. Baker
Publikováno v:
Psychopharmacology. 209:95-102
Despite the popularity of polysubstance abuse among recreational methylendioxymethamphetamine (MDMA) users, relatively few controlled experimental studies have documented the neurobehavioral effects of MDMA in combination with other abused substances
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30d38609ce5ed037f748c78314165d8f
https://doi.org/10.1007/s00213-009-1774-2
https://doi.org/10.1007/s00213-009-1774-2
Autor:
Karen Van Wagner, John J. Panos, Alan Poling, Kelly P. Bradley, Amy Durgin, Lindsay K. Porter, Marc Weeden
Publikováno v:
Experimental and Clinical Psychopharmacology. 17:105-112
This study determined the involvement of women as first authors and other authors for every article published in Experimental and Clinical Psychopharmacology, Pharmacology Biochemistry and Behavior, and Psychopharmacology in 1991, 1996, 2001, and 200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d778594bf7972a14d5084002d69a721
https://doi.org/10.1037/a0015428
https://doi.org/10.1037/a0015428
Autor:
Lisa E. Baker, Mary M. Peet, John J. Panos, Sheryl L. Walker, Larissa Haliw, Bryan A. Killinger, Lisa M. Bell
Publikováno v:
Psychopharmacology. 203:203-211
Research interests regarding the psychopharmacology of salvinorin A have been motivated by the recreational use and widespread media focus on the hallucinogenic plant, Salvia divinorum. Additionally, kappa opioid (KOP) receptor ligands may have thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d88a96315c2aa19863a98c9d6fe1e668
https://doi.org/10.1007/s00213-008-1458-3
https://doi.org/10.1007/s00213-008-1458-3